---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42048860.md"
description: "$Icecure Medical(ICCM.US) surged 235% the previous day on the clinical data from the ProSense cryoablation group, only to give back over ten percentage points the next day. The small-sample data showing 90% non-recurrence for kidney tumors is indeed impressive, but clinical rallies for small-cap medical device stocks can be as fast to retreat as they are to rise. This is profit-taking after the data release, not a new negative catalyst. At this level, should one chase this clinical milestone, or wait for it to digest the previous day's emotional bubble? I'd wait, because a stock that doubles in a day rarely sees its emotional tide recede in just one day."
datetime: "2026-06-22T10:05:32.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42048860.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42048860.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42048860.md)
author: "[股市游侠](https://longbridge.com/en/profiles/27713102.md)"
---

# $Icecure Medical(ICCM.US) surged 235% the previous…


### Related Stocks

- [ICCM.US](https://longbridge.com/en/quote/ICCM.US.md)